Smith & Nephew PLC

SN.: XLON (GBR)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|stLOCK|RMscLOCK|Y#hk#>y

Smith & Nephew Earnings: Weak Orthopedics Growth Drags Down Quarterly Results

Smith & Nephew reported third-quarter underlying revenue growth of 3%, with outsize contribution from sports medicine joint repair that rose 11% year over year.

Sponsor Center